Related Articles
Function of GSK‑3 signaling in spinal cord injury (Review)
Biocompatibility study of a silk fibroin‑chitosan scaffold with adipose tissue‑derived stem cells in vitro
Acute spinal cord injury: Pathophysiology and pharmacological intervention (Review)
HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development (Review)
Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro